Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 25;87(10):2459-2467.
doi: 10.1021/acs.jnatprod.4c00759. Epub 2024 Sep 24.

Computationally-Assisted Discovery and Assignment of a New Class of 6/6/5/5 Fused-Ring Diterpene Acting as Pregnane X Receptor Ligands from Isodon serra

Affiliations

Computationally-Assisted Discovery and Assignment of a New Class of 6/6/5/5 Fused-Ring Diterpene Acting as Pregnane X Receptor Ligands from Isodon serra

Zhiwei Bian et al. J Nat Prod. .

Abstract

We report here the orchestration of molecular ion networking (MoIN) and a set of computationally assisted structural elucidation approaches in the discovery and assignment of a new class of rearranged 4,5-seco-abietane diterpenoids including serra A (1), which possesses an unusual 6/6/5/5 fused-ring skeleton system, together with two previously unreported diterpenoids serras B-C (2-3) and five known compounds were isolated from Isodon serra (I. serra). The structures were elucidated by spectroscopic analysis in conjunction with computationally assisted structure elucidation tools. In silico, serras A-C (1-3) bind well to PXR, suggesting their potential role in reducing inflammation. The results of serra A (1) with hPXR demonstrated agonist activity with an EC50 value of 15 μM. Serra A (1), graciliflorin F (4), gerardianin C (5), 11,12,15-trihydroxy-8,11,13-abietatrien-7-one (6), rabdosin D (7), and 15-hydroxysalprionin (8) exhibited promising anti-inflammatory activities in lipopolysaccharide (LPS)-induced RAW 267.4 cells, and their inhibition rates on NO production were more than 65% at 10 μM.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1.
Figure 1.
Whole MoIN map for the ethanol extract of I. serra. The zoomed out part is for the diterpenoids of the whole MoIN map.
Figure 2.
Figure 2.
Structure and key HMBC (H → C) and COSY (H → H) correlations of serras A–C (1–3).
Figure 3.
Figure 3.
DFT, TDDFT and DP4+ analysis of compounds 2 and 3. Correlations that do not meet this criterion are highlighted in red.
Figure 4.
Figure 4.
Experimental and calculated ECD spectra of serra A (1S) and 13C NMR calculations of serra A (1S).
Figure 5.
Figure 5.
Experimental and calculated ECD spectra of serra B (1R,2R), and serra C (1R,2S) in MeOH.
Figure 6.
Figure 6.
(A) PXR protein structure and binding domain. (B) Binding domain subdivided into subpockets 1–4 with respective ligands. (C) Binding positions and affinities of serra A (1) (pink; −9.4 kcal/mol), oxadiazon (orange; −9.8 kcal/mol), serra B (2) (green; −8.7 kcal/mol), serra C (3) (yellow; −9.5 kcal/mol), α-zearalanol (blue; −10.7 kcal/mol), pretilachlor (red; −7.0 kcal/mol), and estradiol (purple; −9.7 kcal/mol).
Figure 7.
Figure 7.
Interaction of serra A (1) (pink) and oxadizon (orange) with the amino acid residues within the PXR binding domain.
Figure 8.
Figure 8.
Transcriptional responses of PXR in GAL4-hPXR-LBD-transfected Hek293 cells exposed to different concentrations of serra A (1). Assays were performed in triplicate in at least three independent experiments, and data are expressed as the mean (±sd).

References

    1. Dvorak Z; Kopp F; Costello CM; Kemp JS; Li H; Vrzalova A; Stepankova M; Bartonkova I; Jiskrova E; Poulikova K; Vyhlidalova B; Nordstroem LU; Karunaratne CV; Ranhotra HS; Mun KS; Naren AP; Murray IA; Perdew GH; Brtko J; Toporova L; Schon A; Wallace BD; Walton WG; Redinbo MR; Sun K; Beck A; Kortagere S; Neary MC; Chandran A; Vishveshwara S; Cavalluzzi MM; Lentini G; Cui JY; Gu H; March JC; Chatterjee S; Matson A; Wright D; Flannigan KL; Hirota SA; Sartor RB; Mani S EMBO Mol. Med 2020, 12, No. e11621. - PMC - PubMed
    1. Chai SC; Lin W; Li Y; Chen T Drug Discovery Today 2019, 24, 906. - PMC - PubMed
    1. DeKeyser JG; Laurenzana EM; Peterson EC; Chen T; Omiecinski CJ Toxicol. Sci 2011, 120, 381. - PMC - PubMed
    1. Cheng J; Shah YM; Gonzalez FJ Trends Pharmacol. Sci 2012, 33, 323. - PMC - PubMed
    1. Huber AD; Poudel S; Li Y; Lin W; Wu J; Miller DJ; Chen T Structure 2023, 31, 1545. - PMC - PubMed

LinkOut - more resources